Lipella Pharmaceuticals Inc (NASDAQ:LIPO) currently has a daily average trading volume of 2.23M but it saw 1206079 shares traded in last market. With a market cap of 5.43M USD, the company’s current market price of $4.49 came rising about 3.94 while comparing to the previous closing price of $4.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.00 and as low as $2.21. In the recent trading on the day, stock has struck highest price mark of $3.89 while lowest mark touched by it was $4.5.
Taking a look at 20-day trading activity of Lipella Pharmaceuticals Inc (LIPO) gives us an average price of $3.06, while its current price level is -62.58% below from 52-week high level whereas it is 103.17% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.01 while that of 200 days or SMA-200 reads an average of $3.81. A closer look into the stock’s movement over the week reveals that its volatility is standing at 34.58% during that period while stretching the period over a month that decreases to 12.27%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.06 which implies that the stock is in neutral territory.
Over the week, LIPO’s stock price is moving 74.03% up while it is 47.70% when we observe its performance for the past one month. Year-to-date it is 47.21% up and over the past year, the stock is showing a downside performance of -43.88%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Lipella Pharmaceuticals Inc’s total number of outstanding shares is 1.09M with 29.37% of that held by the insiders while 0.88% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -292.24% and return on equity (ROE) at -231.67%. Stock’s beta reads 0.00. Stock has a price to book (P/B) ratio of 3.36 while price to sale or P/S ratio amounts to 11.30. Its return on asset (ROA) is -170.50% on average.
